RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ) FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of RaySearch Laboratories AB (publ) (RAY B.ST) as of Nov 19, 2026 is 157.55 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 131.53 % — a change of 19.78% (higher).

FCF Conversion

157.55 %

YoY

19.78%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of RaySearch Laboratories AB (publ) is 2025 157.55 % . FCF Conversion Rate (FCF/EBITDA) of RaySearch Laboratories AB (publ) was 2024 131.53 % . It decreases by 19.78% higher compared to the previous year.

The RaySearch Laboratories AB (publ) FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-57.51 SEK
Jan 1, 2019
214.44 SEK
Jan 1, 2020
-1,166.46 SEK
Jan 1, 2021
36.06 SEK
Jan 1, 2022
526.86 SEK
Jan 1, 2023
302.31 SEK
Jan 1, 2024
131.53 SEK
Jan 1, 2025
157.55 SEK
The RaySearch Laboratories AB (publ) FCF Conversion history
YEARFCF ConversionYoY
157.55 %+19.78%
131.53 %-56.49%
302.31 %-42.62%
526.86 %+1,361.21%
36.06 %-103.09%
-1,166.46 %-643.97%
214.44 %-472.84%
-57.51 %+4,933.66%
-1.14 %-112.45%
9.18 %-14.87%
10.78 %-185.22%
-12.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RaySearch Laboratories AB (publ) Stock analysis

What does RaySearch Laboratories AB (publ) do? RaySearch Laboratories AB (publ) was founded in Stockholm, Sweden in 2000. The company focuses on the development of software for cancer radiation therapy, including planning, control, and monitoring of radiation doses. RaySearch is a leading provider of software solutions in this field and is globally recognized for its innovative developments and leadership in clinical studies and product approvals. RaySearch Laboratories AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RaySearch Laboratories AB (publ) stock

FCF Conversion Rate (FCF/EBITDA) of RaySearch Laboratories AB (publ) is 157.55 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of RaySearch Laboratories AB (publ) changed from 131.53 % to 157.55 %, representing a 19.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) RaySearch Laboratories AB (publ) since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s RaySearch Laboratories AB (publ) with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — RaySearch Laboratories AB (publ)

All Key Metrics — RaySearch Laboratories AB (publ)